10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The First Case of Catheter-related Bloodstream Infection Caused by Kocuria rhizophila in Korea

      letter
      , M.D. 1 , , M.D. 1 , 2 , , M.D., Ph.D. 2 , 3 , , M.D., Ph.D. 4 , 5 , , M.D. 1 ,
      Annals of Laboratory Medicine
      Korean Society for Laboratory Medicine

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor, Kocuria spp. are gram-positive cocci formerly classified as members of Micrococcus spp. that belong to the family Micrococcaceae [1]. They are commonly found in the environment, including water and soil, and also exist in the mucosa and skin of animals [1 –3]. Among Kocuria spp., Kocuria kristinae and Kocuria varians cause most human infections [2, 3]. Two cases of Kocuria rhizophila infection involving the central venous catheter (CVC) have been reported [4, 5]; however, studies reporting these cases analyzed less than 500 bp of the 16S ribosomal (r) RNA gene, limiting their accuracy. We report the first Korean case of catheter-related bloodstream infection (CRBSI) caused by K. rhizophila, confirmed by genomic evidence. The Institutional Review Board of Seoul National University Hospital, Seoul, Korea, approved this study (2205-142-1327) and waived the need for informed consent. In January 2022, an 18-year-old boy with a vascular-access port for home parenteral nutrition (HPN) was hospitalized because of fever. He had been on HPN for four years because of an avoidant restrictive food intake disorder and was hospitalized for recurrent CRBSIs. On day 1, his temperature was 39.4°C, and a complete blood count indicated a leukocyte count of 3.58×109/L (reference interval [RI]: 4.0–10.0×109/L), with 84.9% neutrophils; the C-reactive protein level was 26.1 mg/L (RI: <5 mg/L). Two pairs of blood samples collected from the peripheral vein (PV) and one pair collected from the CVC were inoculated into BACTEC Peds Plus/F and Lytic/10 Anaerobic/F bottles (Becton Dickinson, Sparks, MD, USA) and incubated in a BACTEC FX Blood Culture System (Becton Dickinson). He received intravenous vancomycin 690 mg at six hours interval as empirical antibiotic therapy. Gram-positive cocci were detected in all aerobic culture bottles. The times to positive results were 17 hours (CVC) and 73 and 75 hours (PV), suggesting CRBSI. Colonies on blood agar were smooth, circular, and cream-colored. The isolates were identified as K. rhizophila using the VITEK 2 GP ID card (bioMérieux, Durham, NC, USA), with an excellent accuracy (99.0%). It was identified at the genus level as K. rhizophila (score value: 1.936) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) using MALDI Biotyper (Bruker Daltonics, Bremen, Germany). Next, 16S rRNA sequence analysis was performed, and the sequence was searched in the GenBank database and interpreted according to CLSI guidelines [6]. The sequence showed 99.93% identity with K. rhizophila (AY030315.1) and 99.79% identity with K. varians (MN072929.1). A phylogenetic tree of the 16S rRNA sequences of the isolate and type strains of the genus Kocuria constructed using MEGA-11 (http://www.megasoftware.net) showed that the isolate formed a clade with K. rhizophila (Fig. 1A). The results of antimicrobial susceptibility tests using Etest (bioMérieux) were interpreted as Micrococcus spp. or Staphylococcus spp. (Table 1) [7]. The fever subsided by the third day of hospitalization, and follow-up blood cultures on day 4 were negative. Because the chemo port was changed only three months prior, vancomycin-lock therapy was started on day 5 to preserve it. Intravenous vancomycin and vancomycin-lock therapy were administered until day 16. There were no additional symptoms after the discontinuation of vancomycin, and the patient was discharged on day 26. Given the high similarity of 16S rRNA sequences of Kocuria spp., whole-genome sequencing (WGS) of the isolate using the MiSeq platform (Illumina, San Diego, CA, USA) was performed within the MAFGEN project [8]. The assembled genome size was 2,771,437 bp; the GC content was 70.57%. Analysis using TrueBac ID (CJ Bioscience Inc., Seoul, Korea) revealed that it shared the highest average nucleotide identity with K. rhizophila (97.76%), followed by K. tytonis (88.10%). The identification was confirmed by a genome-based phylogenetic tree built using the Type Strain Genome Server (TYGS) (Fig. 1B) [9]. The rpoB sequence (3,510 bp) was retrieved from GenBank; it showed 99.94% identity with K. rhizophila (CP072262.1), followed by 94.99% with K. varians (CP059343.1), indicating that the rpoB sequence is useful for identifying Kocuria [6]. Although Kocuria spp. are human commensals, the recent increase in cases of Kocuria infections indicates their pathogenic potential in immunocompromised or chronically catheterized patients [2 –5]. Consistent with the previously reported K. rhizophila infections, the patient had a history of prolonged catheter use and recurrent CRBSIs [4, 5]. CRBSI is a common but significant complication in patients receiving HPN, especially in children [10]. While 16S rRNA sequencing is commonly used for bacterial identification, few organisms, including Kocuria spp., cannot be identified at the species level even with full-length 16S rRNA sequences [6]. WGS is increasingly used in clinical microbiology laboratories, and rare bacterial species can be accurately identified using TruBac ID or TYGS [8, 9]. This is the first case of CRBSI caused by K. rhizophila confirmed with genomic evidence in Korea. The whole-genome sequence of the isolated bacterium was submitted to the BioSample database (accession No.: SAMN32639282).

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          TYGS and LPSN: a database tandem for fast and reliable genome-based classification and nomenclature of prokaryotes

          Microbial systematics is heavily influenced by genome-based methods and challenged by an ever increasing number of taxon names and associated sequences in public data repositories. This poses a challenge for database systems, particularly since it is obviously advantageous if such data are based on a globally recognized approach to manage names, such as the International Code of Nomenclature of Prokaryotes. The amount of data can only be handled if accurate and reliable high-throughput platforms are available that are able to both comply with this demand and to keep track of all changes in an efficient and flexible way. The List of Prokaryotic names with Standing in Nomenclature (LPSN) is an expert-curated authoritative resource for prokaryotic nomenclature and is available at https://lpsn.dsmz.de . The Type (Strain) Genome Server (TYGS) is a high-throughput platform for accurate genome-based taxonomy and is available at https://tygs.dsmz.de . We here present important updates of these two previously introduced, heavily interconnected platforms for taxonomic nomenclature and classification, including new high-level facilities providing access to bioinformatic algorithms, a considerable expansion of the database content, and new ways to easily access the data.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Emerging Bacterial Infection: Identification and Clinical Significance of Kocuria Species

            Recently there have been reports of gram-positive cocci which are morphologically similar to both Staphylococci and the Micrococci. These bacteria have been identified as Kocuria species with the help of automated identification system and other molecular methods including 16S rRNA (ribosomal ribonucleic acid) evaluation. Kocuria belongs to the family Micrococcaceae which also includes Staphylococcus species and Micrococcus species. Isolation and clinical significance of these bacteria from human specimens warrant great caution as it does not necessarily confirm infection due to their ubiquitous presence, and as a normal flora of skin and mucous membranes in human and animals. Most clinical microbiology laboratories ignore such bacteria as laboratory and specimen contaminants. With increasing reports of infections associated with these bacteria, it is now important for clinical microbiologists to identify and enumerate the virulence and antibiotic susceptibility patterns of such bacteria and assist clinicians in improving the patient care and management. We review the occurrence and clinical significance of Kocuria species.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Application of the Whole Genome-Based Bacterial Identification System, TrueBac ID, Using Clinical Isolates That Were Not Identified With Three Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Systems

              Background Next-generation sequencing is increasingly used for taxonomic identification of pathogenic bacterial isolates. We evaluated the performance of a newly introduced whole genome-based bacterial identification system, TrueBac ID (ChunLab Inc., Seoul, Korea), using clinical isolates that were not identified by three matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems and 16S rRNA gene sequencing. Methods Thirty-six bacterial isolates were selected from a university-affiliated hospital and a commercial clinical laboratory. Species was identified by three MALDI-TOF MS systems: Bruker Biotyper MS (Bruker Daltonics, Billerica, MA, USA), VITEK MS (bioMérieux, Marcy l'Étoile, France), and ASTA MicroIDSys (ASTA Inc., Suwon, Korea). Whole genome sequencing was conducted using the Illumina MiSeq system (Illumina, San Diego, CA, USA), and genome-based identification was performed using the TrueBac ID cloud system (www.truebacid.com). Results TrueBac ID assigned 94% (34/36) of the isolates to known (N=25) or novel (N=4) species, genomospecies (N=3), or species group (N=2). The remaining two were identified at the genus level. Conclusions TrueBac ID successfully identified the majority of isolates that MALDI-TOF MS failed to identify. Genome-based identification can be a useful tool in clinical laboratories, with its superior accuracy and database-driven operations.
                Bookmark

                Author and article information

                Journal
                Ann Lab Med
                Ann Lab Med
                Annals of Laboratory Medicine
                Korean Society for Laboratory Medicine
                2234-3806
                2234-3814
                1 September 2023
                21 April 2023
                21 April 2023
                : 43
                : 5
                : 520-523
                Affiliations
                [1 ]Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea
                [2 ]Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea
                [3 ]Department of Laboratory Medicine, Seoul National University Boramae Medical Center, Seoul, Korea
                [4 ]Department of Pediatrics, Seoul National University Children’s Hospital, Seoul, Korea
                [5 ]Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
                Author notes
                Corresponding author: Jae Hyeon Park, M.D. Department of Laboratory Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-2072-7545, Fax: +82-2-747-0359, E-mail: bjack9@ 123456gmail.com
                Author information
                https://orcid.org/0000-0002-6870-9214
                https://orcid.org/0000-0002-2093-1721
                https://orcid.org/0000-0001-7765-2259
                https://orcid.org/0000-0002-0798-6779
                https://orcid.org/0000-0003-0261-2185
                Article
                alm-43-5-520
                10.3343/alm.2023.43.5.520
                10151271
                e024ff8b-bded-4c94-9160-04a7c11a2310
                © Korean Society for Laboratory Medicine

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 21 December 2022
                : 12 January 2023
                : 6 March 2023
                Funding
                RESEARCH FUNDING None declared.
                Categories
                Letter to the Editor
                Clinical Microbiology

                Clinical chemistry
                Clinical chemistry

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content3,711

                Most referenced authors104